In this issue:
Leukaemia selection
Long-term follow-up of CD19 CAR therapy for ALL
First-in-human response of venetoclax in T-cell PLL
Venetoclax for CLL progressing after ibrutinib
Lymphoma selection
PET-guided treatment for advanced-stage Hodgkin’s lymphoma
CAR T-cells in refractory B-cell lymphomas
Brentuximab with chemotherapy for stage III–IV Hodgkin’s lymphoma
Treatment of sporadic Burkitt’s lymphoma in adults
Acalabrutinib for relapsed/ refractory mantle cell lymphoma
R-CHOP-14 ±radiotherapy in nonbulky limited-stage DLBCL
Dose-adjusted EPOCH for untreated PTCLs
High-dose chemotherapy with autologous SCT in primary CNS lymphoma
Please login below to download this issue (PDF)